Evidence map›Paper›PMID 34584518›Full record

ArticleEngineering in life sciences2021

A novel model to culture cells from giant cell tumor of bone using three-dimensional (3D) polycaprolactone scaffold.

Eréndira Estrada-Villaseñor, Margarita Valdés-Flores, Abelardo Meneses-García, Phaedra Silva-Bermudez, Raul Pichardo-Bahena, Pedro Ostoa-Saloma, Gabriela Mercado-Celis, Ernesto D Delgado-Cedillo, Anell Olivos-Meza, Carlos Landa-Solís

Open access · goldAbstract read
In one paragraph

Article in Engineering in life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Eréndira Estrada-VillaseñorPathology Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.
Margarita Valdés-FloresGenetics Laboratory National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.
Abelardo Meneses-GarcíaPathology Service National Cancer Institute Mexico City Mexico.
Phaedra Silva-BermudezTissue Engineering and Cell Therapy Unit National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.
Raul Pichardo-BahenaPathology Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.
Pedro Ostoa-SalomaDepartment of Immunology Institute of Biomedical Research National Autonomous University of Mexico Mexico City Mexico.
Gabriela Mercado-CelisLaboratory of Clinical Genomics Division of Graduate Studies and Research Faculty of Odontology National Autonomous University of Mexico Mexico City Mexico.
Ernesto D Delgado-CedilloBone Tumors Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.
Anell Olivos-MezaSports Orthopedics and Arthroscopy National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.
Carlos Landa-SolísTissue Engineering and Cell Therapy Unit National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico.ORCID https://orcid.org/0000-0002-0680-8516
Instituto Nacional de Rehabilitación · MXUniversidad Nacional Autónoma de México · MXVietnam National Children's Hospital · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing GCTB cells on a polycaprolactone (PCL)-printed scaffold. We also evaluated the viability of the cultured cells and their adherence to the PCL scaffold at day 14 days using immunofluorescence analysis with calcein, vinculin, and phalloidin. Using the histological technique with hematoxylin and eosin staining, we observed all the histological components of GCTB in this 3D model. Immunohistochemical assays with cathepsin K, p63, and receptor activator of nuclear factor (NF)-κB ligand (RANKL) yielded positive results in this construct, which allowed us to confirm that the seeded cells maintained the expression of GCTB markers. Based on these findings, we concluded that the PCL scaffold is an efficient model to culture GCTB cells, and the cell viability and adherence to the scaffold can be preserved for up to 14 days. Moreover, this model can also be used in subsequent studies to assess in vitro cell-cell interactions and antineoplastic efficacy of certain agents to establish a treatment against GCTB.

Indexed as

3D PCL scaffold3D tumor modelsgiant cell tumor of bone

Identifiers

PMID34584518
PMCPMC8456323
OpenAlexW3176200732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.